WeRide Inc. — Capital/Financing Update 2008

Jul 17, 2008

The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for any securities.

==> picture [41 x 41] intentionally omitted <==

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED 遠東生物制藥科技有限公司

(Incorporated in the Cayman Islands with limited liability) (Stock Code: 399)

DISCHARGE OF PROVISIONAL LIQUIDATORS, COMPLETION OF PLACING DOWN AND RESUMPTION OF TRADING

Financial advisor to the Company

==> picture [134 x 38] intentionally omitted <==

The Provisional Liquidators were discharged with effect from 11 July 2008.

On 12 July 2008 the Investor and Goldride Securities Limited entered into the Placing Down Agreement in relation to the Placing Down which was completed on 16 July 2008.

An application has been made to the Stock Exchange for the resumption of trading in the shares of the Company with effect from 9:30 a.m. on Friday, 18 July 2008.

Reference is made to the circular jointly issued by the Company and the Investor dated 28 May 2008 (the "Circular") and the announcement dated 10 July 2008 in relation to the completion of all the conditions set out in the Decision Letter (the “Announcement”). Unless otherwise stated, capitalised terms used herein shall have the same meanings as those used in the Circular and the Announcement.

DISCHARGE OF THE PROVISIONAL LIQUIDATORS

Pursuant to the Hong Kong Court order dated 8 July 2008, the Provisional Liquidators were discharged on 11 July 2008.

1

PLACING DOWN AGREEMENT

On 12 July 2008, the Investor and Goldride Securities Limited (the “Placing Agent”) entered into an agreement in respect of the placing of 726,240,000 Subscription Shares (the “Placing Down”) (the “Placing Down Agreement”) .

Date

12 July 2008

Parties

• (a) the Investor

• (b) Goldride Securities Limited (as the Placing Agent)

The Placing Agent is an Independent Third Party not holding any securities of the Company as at the date of this announcement. It will not hold shares in the Company as a result of the Placing Down Agreement.

Placing Down

Pursuant to the Placing Down Agreement, the Placing Agent has placed 726,240,000 Subscription Shares to not less than six placees, each of them holding less than 5% of the enlarged issued capital of the Company and all of whom are Independent Third Parties.

Completion of the Placing Down took place on 16 July 2008. As a result, the Company has a sufficient Public Float in accordance with the Listing Rules.

SHAREHOLDING STRUCTURE OF THE COMPANY

Set out below is the shareholding structure of the Company after completion of the Placing Down.

Name of	Before		After
Shareholders	the Placing Down		the Placing	Down
	No. of	%	No. of	%
	shares	(approx.)	shares	(approx.)
The Investor	4,133,910,560	67.97	3,407,670,560	56.03
ADM	1,153,846,154	18.97	1,153,846,154	18.97
Subtotal:	5,287,756,714	86.94	4,561,516,714	75.00
The public:
Mr. Cai and Mr. Chen Ching Ken_(Note)_	88,340,000	1.45	88,340,000	1.45
Other public Shareholders	706,157,317	11.61	1,432,397,317	23.55
Total:	6,082,254,031	100.00	6,082,254,031	100.00

2

Note: These Shares were held by Great Wall Investment Group Limited as the trustee of the Great Wall Unit Trust, a unit trust of which all of the units in issue are owned by Ansbacher (BVI) Limited in its capacity as the trustee of The C&C Trust, a discretionary family trust of which the objects include Mr. Cai and his spouse and the family member of Mr. Chen Ching Ken, the then Director. Accordingly, Mr. Chen Ching Ken, as founder of The C&C Trust, and Mr. Cai, as one of the discretionary objects of The C&C Trust, are deemed to be interested in the shares owned by Great Wall Investment Group Limited in its capacity as the trustee of the Great Wall Unit Trust under Part XV of the SFO.

SHARE RESUMPTION

Trading in the Shares on the Stock Exchange was suspended on 17 June 2004 at the direction of the Stock Exchange. An application has been made to the Stock Exchange for the resumption of trading in the shares of the Company with effect from 9:30 a.m. on Friday, 18 July 2008.

By Order of the Board Far East Pharmaceutical Technology Company Limited Tai Kai Hing Director

Hong Kong, 17 July 2008

As at the date of this announcement, the Board comprises two executive Directors, namely Mr. Tai Kai Hing and Ms. Choi Suk Ching, and three independent non-executive Directors, namely Mr. Chiu Koon Shou, Victor, Mr. Chung Wai Man and Dr. Leung Wai Cheung.

Please also refer to the published version of this announcement on the Company’s website: http://www.feptcl-399.info/.

3